Apr 3, 2022
European AxSpA Guidelines Reflect Recent Changes in Drug Therapy
COPENHAGEN, Denmark — European recommendations and overarching principles for the management of patients with axial spondyloarthritis (axSpA) have remained largely unchanged since 2016 – with a few notable but very important exceptions. Dr Sofia Ramiro The 2022 updated recommendations include a new point regarding which biologic agents to use for patients with recurrent uveitis, active